Use of ceftazidime for malignant external otitis.
Ann Otol Rhinol Laryngol
; 98(9): 721-5, 1989 Sep.
Article
en En
| MEDLINE
| ID: mdl-2675731
During the past 2 years we have used ceftazidime (Fortaz), a third-generation cephalosporin, in the treatment of eight patients with progressive necrotizing "malignant" external otitis. Ceftazidime is very active against Pseudomonas species and provides penetration into the CSF. Our results suggest that this medication has several advantages over the previously recommended combinations of aminoglycosides and semisynthetic penicillins, including improved cure rate, lower toxicity, and simpler administration schedules. We review our experience with ceftazidime in the treatment of eight patients.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Osteomielitis
/
Otitis Externa
/
Infecciones por Pseudomonas
/
Ceftazidima
Tipo de estudio:
Etiology_studies
Límite:
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Ann Otol Rhinol Laryngol
Año:
1989
Tipo del documento:
Article
Pais de publicación:
Estados Unidos